Sign in

CIK 0001873835

  • Emerging growth company

Immix Biopharma, Inc.

Sign in to watch
Ticker
IMMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
454869378
Phone
+1 888-958-1084
Business address
11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
Former names
Immix Biopharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-22 Adams Helen C. Director Grant or award +6,250 181,004
2026-05-22 Adams Helen C. Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2025-06-20 Adams Helen C. Director Grant or award · Stock Option (Right to Buy) +33,000 33,000
2024-06-11 Adams Helen C. Director Grant or award · Stock Option (Right to Buy) +33,000 33,000
2024-05-20 Adams Helen C. Director Grant or award +74,241 174,754
2024-05-15 Adams Helen C. Director Grant or award +87,740 100,740
2023-09-12 Adams Helen C. Director Purchase +13,000 $2.96 $38K 13,000
2023-08-11 Adams Helen C. Director Grant or award · Stock Options +20,000 20,000
2022-07-14 Adams Helen C. Director Grant or award · Stock Options +16,000 53,500

Page 1 of 1 · 9 trades